The NHS, like most developed-world healthcare systems, is primarily organised around the treatment of established disease rather than the prevention of it. This organisational reality means that most people engage with the health system reactively, when symptoms emerge and diagnoses are made, rather than proactively, when biological risk factors are accumulating without symptoms. The research on the natural history of the major chronic diseases, including cardiovascular disease, type 2 diabetes, Alzheimer's disease, and most cancers, consistently shows that the biological trajectory toward these conditions begins decades before symptoms appear.
The Asymptomatic Decades
Atherosclerosis, the arterial disease that produces heart attacks and strokes, begins in childhood and progresses silently through adulthood. Studies of young adults killed in accidents have found significant atherosclerotic plaques in the coronary arteries of people in their twenties. The Framingham Heart Study established that the modifiable risk factors for cardiovascular events, including blood pressure, cholesterol, blood glucose, and smoking, are measurable and addressable decades before any event occurs. Similarly, the amyloid deposits associated with Alzheimer's disease are detectable in imaging studies 15 to 20 years before cognitive symptoms emerge.
The Return on Prevention Investment
The economic argument for preventive health investment is straightforward: preventing a disease is substantially cheaper than treating it, and the years of healthy life gained by prevention cannot be purchased by treatment after the disease has advanced. A study by Dariush Mozaffarian and colleagues estimated that dietary improvement alone could prevent approximately 45 per cent of US cardiovascular deaths. Exercise interventions cost a small fraction of the pharmacological treatment of the conditions they prevent. The challenge is that prevention requires investment before symptoms create urgency, which conflicts with the psychological tendency to discount future costs heavily.
Biological Age as a Useful Concept
Biological age, an estimate of the rate at which your body is ageing relative to chronological age, provides a concrete and actionable framework for preventive investment. Unlike chronological age, biological age responds to lifestyle interventions and can be moved in both directions. Assessment tools including telomere length measurement, epigenetic clocks such as the Horvath and GrimAge clocks, and functional assessments of cardiovascular fitness, grip strength, and metabolic markers all provide concrete feedback on biological ageing trajectory that motivates preventive investment in a way that abstract disease risk statistics do not.
Starting Before You Think You Need To
The most common response to preventive health messaging is "I'll deal with that when I need to." The research on disease trajectory makes this rational in the short term but costly in the long term. The most significant modifiable risk for most major chronic diseases is accumulated over decades, and the most significant gains from intervention come from starting early in that accumulation period rather than late. Every year of adequate sleep, regular exercise, nutritious eating, and stress management before symptoms emerge is worth more for long-term health than any equivalent intervention taken after symptoms have appeared.